Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: Power Doppler signal predicts short-term relapse
Rheumatology, 07/01/09
Scirè CA et al. – In a cohort of early RA patients treated with conventional DMARDs, ultrasonographic-grey scale (US-GS) can detect residual disease activity more sensitively than clinical examination both in active disease and in remission. Moreover, power Doppler (PD)-positive synovial hypertrophy identifies an ongoing inflammation even during remission and predicts short-term relapse.
Methods- Aim was to evaluate the usefulness of a systematic musculoskeletal US assessment in detection of residual disease activity in pts with early RA who achieved clinical remission
- 106 early RA pts receiving conventional DMARDs according to DAS-steered therapeutic protocol over a 24-mo period
- Standard evaluation included clinical, laboratory, functional and systematic (44 joints) US assessment
- US indexes of GS and PD synovitis were correlated with clinical evaluation, laboratory indexes and clinical outcome
- Clinical remission was defined when DAS was <1.6 at 2 consecutive visits 3 mo apart
- US examination was more sensitive than clinical examination, both in active disease and in remission
- In pts with an active disease, both clinical and US indexes correlated with CRP, whereas in remission only PD still remained correlated
- In clinical remission, 95% of pts showed residual GS synovitis, and 41% of them showed a positive PD signal
- Positive PD signal, even in a single joint, resulted the main predictor of relapse within 6 mo
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of polymyalgia rheumatica
Archives of Internal Medicine, 11/10/09
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
Arthritis Care and Research , 11/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


